MA-BOSE-CORPORATION
Nissan Motor Corporation has selected Bose for a 2017 Global Supplier Award in the field of automotive innovation for creating the first-of-its-kind Bose® Personal® sound system in the all-new Nissan Micra.
Each year, Nissan recognizes quality, excellence, and innovation from its global network of suppliers. And Bose is just one of eight suppliers -- among the thousands of companies working with Nissan -- spotlighted this year as a key contributor to the auto maker’s efforts to increase product competitiveness through innovative offerings.
“We are incredibly honored to receive this award from Nissan,” said Marc Mansell, vice president, Bose Automotive Systems. “We have a dedicated team of people who work very hard -- obsessing over every detail -- to create new technologies and products that people love. It’s what we strive for every day. So, it is tremendously rewarding to earn this kind of recognition.”
This is the second time in three years that Bose has been recognized by Nissan for supplier excellence. In 2015, Bose won a Global Quality Award for its contributions in the field of automotive electronics.
ABOUT THE BOSE PERSONAL SOUND SYSTEM
The award-winning Bose
Personal system sets a new standard for small-car audio by delivering a
superior, driver-focused listening experience inside the compact cabin
of the fully re-designed Micra, which debuted in Europe in the spring of
2017.
Optimized for the driver’s seat -- the only cabin position occupied 100 percent of the time -- the Bose Personal system uses Bose UltraNearfield™ headrest speakers, combined with Bose PersonalSpace™ Virtual Audio Technology, to produce a wide sound field with musical clarity and depth that would otherwise require far more speakers. The Bose Personal system in the Micra has just six speakers in total, including the two in the driver’s seat headrest.
Bose has provided custom-engineered audio systems and technologies to Nissan vehicles for nearly 30 years. For more information about the Bose Personal system, visit BoseSmallVehicle.co.uk
ABOUT BOSE AUTOMOTIVE SYSTEMS
In the early 1980s, Bose engineers
created the world’s first factory-installed premium automotive sound
systems. Unlike conventional or aftermarket automotive systems, Bose
systems were designed and tuned for a specific vehicle -- and changed
the industry. Since then, Bose has developed proprietary speaker
designs, advanced amplification and signal processing technologies,
exclusive
analysis and design tools, and technology for managing
engine and powertrain sounds inside vehicles -- all based on a heritage
of research and engineering.
Today, Bose automotive sound systems are recognized globally as the industry benchmark for performance and customer satisfaction, validated by independent research rating Bose as the top choice among car consumers in multiple global regions. For more information, visit BoseAutomotive.com.
ABOUT BOSE CORPORATION
Bose Corporation was founded in 1964 by Dr.
Amar G. Bose, then a professor of electrical engineering at the
Massachusetts Institute of Technology. Today, the company is driven by
its founding principles, investing in long-term research with one
fundamental goal: to develop new technologies with real customer
benefits. Bose innovations have spanned decades and industries, creating
and transforming categories in audio and beyond. Bose products for the
home, in the car, on the go and in public spaces have become iconic,
changing the way people listen to music.
Bose Corporation is privately held. The company’s spirit of invention, passion for excellence, and commitment to extraordinary experiences can be found around the world -- everywhere Bose does business.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170713005492/en/
Contact:
Bose
Kevin Doak, 508-766-7788
kevin_doak@bose.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom